V.P. Stus
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Renal cell carcinoma treatment 21
- Epidemiology 11
- Urinary Tract Infections Management 7
- Co-authors
- Elizabeth R. Plimack (12 shared papers)Rustem Gafanov (12 shared papers)Brian I. Rini (12 shared papers)Frédéric Pouliot (12 shared papers)Denis Soulières (11 shared papers)Dmitry Nosov (11 shared papers)Delphine Borchiellini (11 shared papers)Bohuslav Melichar (10 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)European Urology (3 papers)The Lancet Oncology (3 papers)Clinical Infectious Diseases (2 papers)Open Forum Infectious Diseases (2 papers)
- Partner nations
- United StatesUkraineRussia
In The Last Decade
V.P. Stus
31 papers receiving 1.8k citations
V.P. Stus's Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Medicine 278
- Applied Microbiology and Biotechnology 89
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 297
- Oncology 479
Countries citing papers authored by V.P. Stus
This map shows the geographic impact of V.P. Stus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.P. Stus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.P. Stus more than expected).
Fields of papers citing papers by V.P. Stus
This network shows the impact of papers produced by V.P. Stus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.P. Stus. The network helps show where V.P. Stus may publish in the future.
Co-authors
The 25 scholars most cited alongside V.P. Stus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial Hit paper breakdown → | 2020 | 514 |
| 2 | Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial Hit paper breakdown → | 2013 | 321 |
| 3 | 2019 | 293 | |
| 4 | 2019 | 107 | |
| 5 | 2019 | 87 | |
| 6 | 2023 | 79 | |
| 7 | 2021 | 76 | |
| 8 | 2023 | 68 | |
| 9 | 2016 | 49 | |
| 10 | 2023 | 48 | |
| 11 | 2020 | 47 | |
| 12 | 2013 | 27 | |
| 13 | 2022 | 22 | |
| 14 | 2017 | 13 | |
| 15 | 2019 | 11 | |
| 16 | 2024 | 8 | |
| 17 | 2021 | 8 | |
| 18 | The role of lead in the etiopathogenesis of male fertility reduction. | 2019 | 6 |
| 19 | 2024 | 5 | |
| 20 | 2021 | 5 |
About V.P. Stus
V.P. Stus is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology, Surgery and Oncology, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (21 papers), Renal and related cancers (7 papers), Urinary Tract Infections Management (7 papers), Cancer Genomics and Diagnostics (6 papers), Urinary Bladder and Prostate Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Economic and Financial Impacts of Cancer (5 papers) and Bladder and Urothelial Cancer Treatments (5 papers). The work is most often cited by research in Molecular Medicine (278 citations), Applied Microbiology and Biotechnology (89 citations), Pulmonary and Respiratory Medicine (1.1k citations), Cancer Research (297 citations) and Oncology (479 citations). V.P. Stus has collaborated with scholars based in United States, Ukraine and Russia. Frequent co-authors include Elizabeth R. Plimack, Rustem Gafanov, Brian I. Rini, Frédéric Pouliot, Denis Soulières, Dmitry Nosov, Delphine Borchiellini, Bohuslav Melichar, Ihor Vynnychenko and Jens Bedke. Their work appears in journals such as Journal of Clinical Oncology, European Urology, The Lancet Oncology, Clinical Infectious Diseases and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.